Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
OVERLAP
31%
OVERLAP
BY WEIGHT
6
# OF OVERLAPPING
HOLDINGS
XLV
60
HOLDINGS
10%
ALSO IN THNR
THNR
18
HOLDINGS
33%
ALSO IN XLV
SECTOR DRIFT (XLV minus THNR)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XLV |
Weight in THNR |
Overlap | |
|---|---|---|---|---|
| ELI LILLY & CO | 14.4% | 15.6% | 14.4% | |
| ABBVIE INC | 7.2% | 4.8% | 4.8% | |
| MERCK & CO. INC. | 4.5% | 5.5% | 4.5% | |
| AMGEN INC | 3.2% | 7.3% | 3.2% | |
| PFIZER INC | 2.7% | 4.9% | 2.7% | |
XLV Overweight Relative to THNR
| JOHNSON & JOHNSON | 8.7% | |
| UNITEDHEALTH GROUP INC | 5.4% | |
| ABBOTT LABORATORIES | 3.9% | |
| THERMO FISHER SCIENTIFIC INC | 3.9% | |
| INTUITIVE SURGICAL INC | 3.7% | |
| GILEAD SCIENCES INC | 2.7% | |
| BOSTON SCIENTIFIC CORP | 2.6% | |
| DANAHER CORP | 2.6% | |
| ABBVIE INC | 2.4% | |
| MEDTRONIC PLC | 2.3% |
XLV Underweight Relative to THNR
| NOVO-NORDISK A/S-SPONS ADR | -10.3% | |
| CHUGAI PHARMACEUTICAL CO LTD | -7.3% | |
| REGENERON PHARMACEUTICALS | -6.5% | |
| ROCHE HOLDING LTD | -5.4% | |
| ASTRAZENECA PLC-SPONS ADR | -5.2% | |
| INNOVENT BIOLOGICS, INC. | -4.5% | |
| SHIONOGI & CO LTD | -4.4% | |
| AMGEN INC | -4.1% | |
| CHINA PHARMACEUTICAL GROUP | -3.6% | |
| HIMS & HERS HEALTH, INC. CLASS A | -3.5% |